I
SRPT icon

InceptionR’s Sarepta Therapeutics SRPT Stock Holding History

InceptionR’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-16,091
Closed -$346K – 888
2025
Q4 		$346K Buy
+16,091
New +$339K 0.1% 388
2025
Q2 		– Sell
-8,880
Closed -$567K – 837
2025
Q1 		$567K Sell
8,880
-2,028
-19% -$213K 0.17% 246
2024
Q4 		$1.33M Buy
+10,908
New +$1.34M 0.3% 95
2024
Q1 		– Sell
-3,061
Closed -$295K – 722
2023
Q4 		$295K Sell
3,061
-163
-5% -$15.6K 0.21% 226
2023
Q3 		$391K Buy
3,224
+1,195
+59% +$135K 0.22% 201
2023
Q2 		$232K Buy
+2,029
New +$262K 0.12% 333
2023
Q1 		– Sell
-3,402
Closed -$441K – 581
2022
Q4 		$441K Buy
+3,402
New +$394K 0.23% 188

Other funds holding SRPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

InceptionR's SRPT Position: Q1 2026 in Review

InceptionR sold out of Sarepta Therapeutics (SRPT) in Q1 2026, closing a stake of 16,091 shares — an estimated $346K sold.

InceptionR first reported a position in SRPT in Q4 2022 and held it in 7 quarters. The position peaked at $1.33M in Q4 2024. 339 funds tracked by Wall St. Rank hold SRPT as of Q1 2026.

  • InceptionR reported no remaining Sarepta Therapeutics position as of Q1 2026 after selling out during the quarter.
  • InceptionR sold 16,091 Sarepta Therapeutics shares in Q1 2026, an estimated $346K.
  • InceptionR first reported a position in Sarepta Therapeutics in Q4 2022 and held it in 7 quarters.
  • InceptionR's Sarepta Therapeutics position peaked at $1.33M in Q4 2024.
  • 339 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q1 2026.

Based on InceptionR's 13F filing for Q1 2026, filed 14 May 2026.